AbbVie Inc. (FRA:4AB)
Germany · Delayed Price · Currency is EUR 169.80
-2.00 (-1.16%)
Last updated: Aug 13, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Immunology | 26.68B | Log In | Log In | Log In | Log In | Upgrade |
Immunology Growth | 8.27% | Log In | Log In | Log In | Log In | Upgrade |
Oncology | 6.56B | Log In | Log In | Log In | Log In | Upgrade |
Oncology Growth | 7.89% | Log In | Log In | Log In | Log In | Upgrade |
Other Key Products | 3.65B | Log In | Log In | Log In | Log In | Upgrade |
Other Key Products Growth | -4.24% | Log In | Log In | Log In | Log In | Upgrade |
All Other | 3.03B | Log In | Log In | Log In | Log In | Upgrade |
All Other Growth | -10.42% | Log In | Log In | Log In | Log In | Upgrade |
Neuroscience | 9.00B | Log In | Log In | Log In | Log In | Upgrade |
Neuroscience Growth | 19.03% | Log In | Log In | Log In | Log In | Upgrade |
Women's Health | - | Log In | Log In | Log In | Log In | Upgrade |
Women's Health Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Aesthetics | 5.18B | Log In | Log In | Log In | Log In | Upgrade |
Aesthetics Growth | -6.31% | Log In | Log In | Log In | Log In | Upgrade |
Eye Care | 2.24B | Log In | Log In | Log In | Log In | Upgrade |
Eye Care Growth | -3.10% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 43.03B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 5.97% | Log In | Log In | Log In | Log In | Upgrade |
International | 13.31B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | 6.31% | Log In | Log In | Log In | Log In | Upgrade |